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Endogenous creatinine clearance (Ccr) is widely accepted
as an estimate of glomerular filtration rate (GFR), the best
overall biomarker of kidney function. However, current
common methods of measuring creatinine are not sensitive
enough for mouse plasma. Accordingly, we here report
a new method of measuring creatinine by liquid
chromatography tandem mass spectrometry (LC-MS/MS)
using deuterated [2H3]-creatinine as an internal standard.
The assay requires 10 ll or less of plasma or urine, and is
eight times more sensitive than high-performance liquid
chromatography. The reproducibility of the assay of
replicates is approximately 710%. The plasma creatinine
levels of wild type male C57BL/6J mice obtained by LC-MS/
MS are 0.07670.002 mg/dl (n¼ 65). To estimate daily urinary
creatinine excretion for calculating Ccr, we collected urine
from mice housed in metabolic cages, and combined this
with washes from the cage internal surfaces. Creatinine in the
wash varies from 4 to 67% of the total daily urinary creatinine
excretion (typicallyB400 lg/day). Ccr obtained by LC-MS/MS
was 329717 ll/min, which is indistinguishable from GFR
measured by using fluorescein isothiocyanate-inulin. The
LC-MS/MS method is sensitive, specific, simple, fast, and
inexpensive; it is suitable for estimating GFR in conscious
mice or other small animals. As it allows repeated
measurements in the same animals, it facilitates detection
of subtle differences or changes in renal function.
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Glomerular filtration rate (GFR) is the best overall biomarker
of kidney function. The gold standard for GFR determination
depends on measuring the clearance of a small molecule
such as inulin that is completely filtered in the glomeruli,
is not reabsorbed or secreted by renal tubules, and is not
metabolized or secreted anywhere else in the body. However,
the use of fluorescein isothiocyanate (FITC)-inulin could
trigger the generation of antibodies against it in mice, which
makes the use of FITC-inulin not suitable for measuring GFR
repeatedly over the period of months in the same animals.
Creatinine clearance (Ccr) is an acceptable alternative.
However, current common methods of measuring creatinine
are not sufficiently sensitive enough for use with mouse
plasma.1–3 Consequently, although more and more mouse
models of human diseases have been generated by gene
targeting and transgenic techniques, the lack of a simple and
reliable method to accurately measure creatinine in mouse
plasma and urine has limited the identification of genetic and
environmental factors that affect kidney function. The most
prevalent methods to measure creatinine in human samples
are the alkaline picrate method using Jaffe´’s reaction,4 and the
enzymatic method using creatinine amidohydrolase, creatine
amidinohydrolase, sarcosine oxidase, and peroxidase, mod-
ified from Moss et al.5 High-performance liquid chromato-
graphy (HPLC) with ultraviolet (UV) detection is an
alternative method for measuring plasma creatinine, but
proteins in the samples need to be eliminated before applying
samples to the HPLC column,6 which introduces errors due
to various recovery rates. Moreover, if molecules that have
the same retention time as creatinine exist in the samples,
HPLC may not be specific for creatinine. The use of liquid
chromatography combined with mass spectrometry has been
reported to measure creatinine in human plasma,7 but mouse
plasma often gives a lot of background with this method
(our unpublished observations). We have therefore deve-
loped a new method of measuring creatinine using an
internal standard labeled with a non-radioactive stable
isotope combined with liquid chromatography, electrospray
ionization, and tandem mass spectrometry (LC-MS/MS) to
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increase the specificity and reduce background. This method
is sensitive, specific, simple, fast, inexpensive, requires very
small amount of body fluid, and allows repeated measure-
ments in the same animals.
RESULTS
Specificity, reproducibility, and sensitivity of creatinine
measurement using LC-MS/MS
In developing our new procedure we determined the limit of
detection and reproducibility of measuring creatinine by
LC-MS/MS. First, synthetic standard solutions of creatinine
and creatinine-N-methyl-D3 ([2H3]-creatinine) were quanti-
fied by UV spectrometry using the published absorption
coefficient (x0 l¼ 240) of 6900.
8 Variability of UV measure-
ment was 77%. These solutions were used to prepare
calibration solutions. The calibration solutions, containing
different amounts of creatinine and a constant amount
(2950 pg) of [2H3]-creatinine, were used for instrument
calibration and quality control during sample analysis.
Creatinine and [2H3]-creatinine both have the same retention
time of approximately 2.2 min, but their mass-to-charge
ratios (m/z) when ionized differ, being 114 and 117, respec-
tively. When creatinine is fragmented, the main fragment
observed has an m/z of 44. When [2H3]-creatinine is
fragmented, the corresponding peak has an m/z of 47. The
LC-MS/MS method combines these features by examining
HPLC peaks that have retention time of 2.2 min, and tandem
mass spectrometer fragments with m/z transition of 114
to 44 for creatinine, or 117 to 47 for [2H3]-creatinine. This
combination makes the LC-MS/MS method more specific
than either HPLC or liquid chromatography combined with
mass spectrometry. Thus no [2H3]-creatinine peak was
detected in our creatinine standard, and no creatinine peak
was detected in our [2H3]-creatinine standard by LC-MS/MS,
indicating no cross-talk between the two materials.
The instrument outputs data in the form of (area of
creatinine peak) which has a retention time of 2.2 min and an
m/z transition of 114 to 44C(area of [2H3]-creatinine peak)
which has a retention time of 2.2 min and an m/z transition
of 117 to 47, and we found this ratio to be linear with a
regression coefficient of 0.995 over a range of 17–1720 pg of
creatinine/injection, which covers the range likely from real
samples (Figure 1). The amount of creatinine in the sample is
calculated as the ratio of (area of creatinine peak)C(area of
[2H3]-creatinine peak) (the amount of [2H3]-creatinine
initially added to the sample) (a response factor). The
response factor (1.16) corrects the difference in ioniza-
tion efficiency of creatinine and [2H3]-creatinine, and the
response of the detector to them. It was determined with
the calibration solution as (creatinine concentration area
of [2H3]-creatinine peak)C([
2H3]-creatinine concentra-
tion area of creatinine peak). The reproducibility for
analyses of urine and plasma was711% (standard deviation)
and 715%, respectively, as determined by six repetitive
analyses of one urine and one plasma sample. The limit of
detection was 30 pg/5 ml injection, with a signal to noise ratio
greater than 10. In effect this means that the method can
be used to measure creatinine concentrations as low as
0.013 mg/dl of creatinine. This represents approximately
eightfold higher sensitivity compared to previously published
HPLC-UV method.6
Measuring mouse urine creatinine using LC-MS/MS
For method comparison, we next determined urinary
creatinine concentrations in several strains of mice by
LC-MS/MS, Jaffe´’s alkaline picrate method, and the enzy-
matic method. Representative ion chromatograms of creati-
nine from a mouse urine sample are shown in Figure 2. In the
upper panel the only peak observed with a transition of 114
to 44 is creatinine eluting at 2.2 min. In the lower panel
the only peak observed with a transition of 117 to 47 is
[2H3]-creatinine eluting at 2.2 min. (The signal at 1 min is
caused by switching the effluent flow from waste to the
LC-MS/MS, and does not represent a real compound.) The
creatinine concentration in this sample is calculated as shown
in the legend of Figure 2.
Figure 3a–e compares the creatinine concentrations
measured by three methods. Values obtained by Jaffe´’s
method were 20% higher than those measured by LC-MS/
MS (Figure 3d, Po0.0001). The enzymatic method also
gave higher values than LC-MS/MS, especially when urine
volumes were larger, and when urine creatinine concentra-
tions were lower (Figure 3c). The enzymatic method
gave more than 10 times higher values in some samples
than LC-MS/MS, revealing major differences (Figure 3e).
Measuring murine plasma creatinine using LC-MS/MS
It has been difficult to determine plasma creatinine
concentrations in mice, because they are approximately 100
times lower than those of urine, and because the current
common methods of creatinine measurement lack sufficient
sensitivity for measuring mouse plasma creatinine in the
small volume of plasma available. For an accurate determina-
tion of GFR in mice, one goal is to establish a highly sensitive
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Figure 1 | Calibration curve for creatinine. Constant amount
(2950 pg) of [2H3]-creatinine mixed with various amounts
(17–1720 pg) of creatinine were tested by LC-MS/MS. The ratios of
(area of creatinine)C(area of [2H3]-creatinine) by LC-MS/MS are
plotted against the amount of creatinine injected.
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method for quantitation of plasma creatinine. Therefore,
plasma samples were analyzed from mice using LC-MS/MS.
Creatinine was easily detected in all plasma specimens
and representative ion chromatograms are shown in
Figure 4. The plasma creatinine values of wild-type male
mice (3–6 months of age) measured by LC-MS/MS were
0.07670.002 mg/dl (n¼ 65), whereas the mean plasma
creatinine values measured by HPLC in the literature are
0.10–0.22 mg/dl,6,9,10 suggesting that HPLC overestimates the
concentration of creatinine in mouse plasma.
Mouse Ccr
Using the urine and plasma creatinine values, Ccr (ml/min) is
calculated as total daily urinary creatinine excretion
(mg/day)Cplasma creatinine concentration (mg/ml)C1440
(to convert day to min). However, with the animals as small
as mice it is difficult to obtain accurate estimates of daily
urinary creatinine excretion because in metabolic cages with
the inner diameter of 15 or 20 cm, there is often no urine in
the urine collection tube with normal adult mice, showing
that significant amounts of urine have either evaporated to
dryness or been lost. To overcome this difficulty, we reduced
the inner diameter of the domicile portion of the metabolic
cages to 10 cm, which reduces the fraction of urinary
creatinine retained on the cage internal surfaces. More
importantly, we rinsed the internal surfaces of the cages with
20 ml of water, measured the creatinine content of the rinse
by LC-MS/MS, and added this to the amount of creatinine in
the urine collection tubes to obtain an accurate excretion of
total daily urinary creatinine. (Jaffe´’s method is not sensitive
enough to measure creatinine in the wash, which makes
LC-MS/MS superior to Jaffe´’s method in accurate determina-
tion of urinary creatinine excretion.) The importance of this
is illustrated by noting that the amount of creatinine
remaining on the cages varies from 4 to 67% (median 6%,
mean 11%) of the total daily urinary creatinine excretion.
If food was present in the urine collection tubes, or the
funnels of the cages were clogged with food, samples were
excluded. In these cases an accurate measurement of daily
urinary creatinine excretion is not possible as 1 g of normal
chow contains 160 mg creatinine measured by LC-MS/MS.
Using this LC-MS/MS method, the Ccr of 6-month-old
male wild-type C57BL/6J mice in this study was 329717 ml/
min/mouse (Table 1). When 24 h Ccr and FITC-inulin
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Figure 2 | Ion chromatograms of mouse urine creatinine
measurement using LC-MS/MS. The sample was prepared as
described in Materials and Methods. The upper and lower panels
show ion transition of m/z (mass-to-charge ratio) from 114 to 44
and from 117 to 47 for creatinine and [2H3]-creatinine, respectively,
both having the same retention time (2.2 min). The areas under
the curves of creatinine and [2H3]-creatinine shown in gray are
788800 and 275166, respectively. The creatinine concentration
of this urine is 788800C275166 0.96 ng/ml (concentration of
internal standard) 1.16 (response factor) 100 (dilution
factor)¼ 319 ng/ml¼ 31.9 mg/dl.
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Figure 3 | Comparison of mouse urine creatinine measured by LC-
MS/MS, Jaffe´’s and enzymatic methods. Mouse urine creatinine
measured by (a) LC-MS/MS, (b) Jaffe´’s alkaline picrate method, and (c)
the enzymatic method plotted against daily urine volume. (d and e)
Urine creatinine concentrations measured by Jaffe´’s method and the
enzymatic method plotted against those measured by LC-MS/MS.
Closed gray circle: wild-type controls (n¼ 32); open black circle:
diabetic mice (n¼ 39); red square: furosemide-sensitive kidney-
specific NaK2Cl cotransporter NKCC2 (Slc12a1)-deficient mice
(n¼ 4);12 blue diamond: Ren1c-deficient mice (n¼ 6).16 Solid lines
show linear fit lines. d: y¼ 1.85þ 1.21x, R2¼ 0.92. e: y¼ 25.1þ 0.8x,
R2¼ 0.71. Dashed lines show lines of equivalence.
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clearance were measured in the same animals simultaneously,
Ccr measured by LC-MS/MS was 311711 ml/min and FITC-
inulin clearance was 291724 ml/min (n¼ 7). The difference
between them was 20717 ml/min, which was not different
from zero (P¼ 0.28). There was a significant correlation
between the two methods (R2¼ 0.58, P¼ 0.04). These results
demonstrate that tubular secretion of creatinine is minimal,
and that 24-h Ccr measured by LC-MS/MS is suitable for
estimating 24-h GFR.
Ccr was also examined in age-matched male C57BL/6J
mice that have been diabetic for 3 months after the onset
of streptozotocin-induced hyperglycemia (Table 1). Diabetic
mice tended to eat and urinate more, but their plasma
creatinine concentration, daily urinary creatinine excretion,
and Ccr were similar to those of non-diabetic control mice.
In contrast, mice lacking Ren1c weighed less, urinated more,
and showed higher plasma creatinine concentration and
lower Ccr compared to those of control mice, suggesting that
GFR of the Ren1c/ mice was decreased.
DISCUSSION
Accurate and specific quantitation of plasma creatinine in
mice has been a problem in estimating GFR. We report here
the suitability of LC-MS/MS for quantitation of creatinine in
small (10 ml) volumes of mouse plasma and urine to calculate
Ccr. Our method of LC-MS/MS has distinct advantages over
others. As the LC-MS/MS includes an internal standard, not
present in other methods, this greatly increases the accuracy
of our method. In addition, because LC-MS/MS selects peaks
with m/z transition of 114 to 44 for creatinine and 117 to 47
for [2H3]-creatinine that have retention time of 2.2 min,
LC-MS/MS significantly increases specificity and reduces
background noise (and hence limit of detection) compared
to HPLC or liquid chromatography combined with mass
spectrometry. LC-MS/MS is approximately eight times more
sensitive than HPLC-UV. The most common methods for
creatinine measurements, Jaffe´’s alkaline picrate and the
enzymatic methods lack sufficient sensitivity for analysis of
plasma creatinine in mice.
Creatinine concentration in the urine measured by the
LC-MS/MS method was lower compared to the enzymatic
and Jaffe´’s methods. The enzymatic method depends on
first converting creatinine to creatine; it consequently does
not discriminate creatinine from creatine.5 As mouse urine
contains an equal or higher amount of creatine compared to
creatinine,11 the enzymatic method is not suitable for urine
creatinine analysis in mice. The error becomes especially large
when the urine volumes are larger thanB8 ml/day, such as in
diabetic mice and in furosemide-sensitive NaK2Cl-deficient
mice,12 probably because at high urine volumes absorption of
creatine in tubular fluid is less complete.13
The Ccr value obtained by HPLC (255 ml/min/mouse)6 is
lower than our values, which is probably because HPLC
overestimates the concentration of creatinine in plasma more
than in urine, as plasma contains non-creatinine substances
that have the retention time indistinguishable from that of
creatinine. The abundance of these substances could reach
B60% of that of creatinine (our unpublished observation by
liquid chromatography combined with mass spectrometry).
With essentially no sample workup and relative fast analysis
time, the LC-MS/MS method is applicable to studies with
large sample numbers that require fast turn around (high
throughput). Currently the analysis takes less than 8 min per
sample and future improvements using ultra high pressure
LC-MS/MS can potentially reduce the analysis time by a
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Figure 4 | Ion chromatograms of mouse plasma creatinine
measurement using LC-MS/MS. The sample was prepared as
described in Materials and Methods. The top and bottom panels
show ion transition of m/z from 114 to 44 and from 117 to 47
for creatinine and [2H3]-creatinine, respectively. Creatinine and
[2H3]-creatinine were retained for 2.2 min, and the areas under the
curve shown in gray are 118860 and 223286, respectively. Creatinine
concentration of this plasma is 118860C223286 0.96 ng/ml
(concentration of internal standard) 1.16 (response
factor)¼ 0.59 ng/ml¼ 0.059 mg/dl.
Table 1 | Renal function of 6-month-old male C57BL/6J mice
Body
weight (g)
Food
intake (g)
Plasma glucose
(mg/dl)
Urine volume
(ml/day)
Plasma creatinine
(mg/dl)
Urine creatinine
(lg/day)
Creatinine
clearance (ll/min)
Control (n=10) 33.271.2 4.770.2 144718 1.570.2 0.08970.005 417745 329717
Diabetes (n=13) 31.071.1 5.870.4 393726** 3.871.6 0.10170.009 474752 350744
Ren1c/ (n=6) 25.471.4* 5.770.4 ND 6.670.8* 0.20770.021* 477731 167717*
ND, not determined.
Diabetic mice were made diabetic using streptozotocin and have been diabetic for 3 months. Plasma and urine creatinine was measured by LC-MS/MS.
*Po0.05 and **Po0.001.
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factor of 5–10,14 which will make the analysis even faster. The
costs of LC-MS/MS and of the enzymatic method are similar,
and the availability of mass analyzers is rapidly increasing.
A major challenge of measuring Ccr using metabolic cages
with small animals is to completely recover urinary
creatinine. Our metabolic cages are designed to minimize
the amount of creatinine retained in the cages as a result of
evaporation. We demonstrate a simple correction for this
problem, easily executed in combination with the LC-MS/MS
method, namely the need to rinse the cages and estimate
creatinine in the rinse fluid. Amount of creatinine remaining
on the metabolic cages varied from 4 to 67% of total daily
urinary creatinine excretion, indicating the importance of
rinsing cage internal surfaces to completely recover urinary
creatinine. Food contamination was minimal in our experi-
ments, but to minimize contamination of creatinine from the
food the use of vegetarian diets should be helpful. Indeed,
creatinine in our regular chow is 160 mg/g, whereas in
vegetarian diets it is less than 2 mg/g in three diets that we
tested using LC-MS/MS.
In conclusion, LC-MS/MS enables us to repeatedly
measure plasma and urine creatinine and estimate GFR in
conscious mice and other small animals without the
complications of significant blood loss and difficulties owing
to retention of urine in the metabolic cages. LC-MS/MS is
expected to be sensitive enough to monitor mild progressive
exacerbation of kidney function such as in diabetic nephro-
pathy. It also makes it much easier to calculate fractional
excretions of electrolytes and other substances. LC-MS/MS is
simple, sensitive, specific, inexpensive, and requires no
radioactive materials. It should therefore be applicable for a
wide variety of species, for many types of investigation where
estimation of kidney function are required.
MATERIALS AND METHODS
Materials
Creatinine was from Sigma (St Louis, MO, USA), and creatinine-
N-methyl-D3 ([2H3]-creatinine) was from Cambridge Isotope
Laboratory (Cambridge, MA, USA). All other solvents and reagents
were from Fisher and American Chemical Society grade or higher.
General
All animal experiments were conducted in accordance with
the guidelines of IACUC at UNC. Some mice were made diabetic
by intraperitoneally injecting streptozotocin (40 mg/kg/day for 5
consecutive days) or vehicle (citrate buffer) as described pre-
viously,15 and were observed daily for their general health. Mice
were considered diabetic if blood glucose level exceeded 300 mg/dl.
All animals were fed Laboratory Rodent Diet 5001 (Lab Diet,
Richmond, IN, USA).
Kidney function tests
Individual mice were housed in metabolic cages designed for mouse
renal function studies.12,16 Body weight, the amount of food and
water intakes, and urine volume in 24 h were monitored for 2
consecutive days (48 h). Wire mesh and the bottom of collection
vessel of the cages were washed with 20 ml water every 24 h to
recover the urine adhering to the cages. Urine samples of the latter
24 h were used to measure urine creatinine. Blood was drawn to
measure plasma creatinine at the end of the 48 h to avoid perturbing
physiological steady state GFR.16 Because mice are inactive and their
food intake is minimal in the daytime, the plasma creatinine in the
afternoon is considered to be least affected by muscle activity
and food-derived creatinine. Therefore, setting up cages and
collecting samples were carried out between 15:00 and 16:00. It is
important to set up metabolic cages and draw blood at the same
time for all animals to eliminate the effect of circadian variation of
plasma creatinine. Plasma and urine samples were kept at 201C
until analysis. Many of the previously collected urine samples were
also used for method comparison. For comparison to the novel LC-
MS/MS method urinary creatinine was also determined by the
enzymatic method using a VT250 Chemical Analyzer (Johnson &
Johnson, New Brunswick, NJ, USA),16 and Jaffe´’s alkaline picrate
method using a kit (Exocell Inc., Philadelphia, PA, USA). For these
methods urine samples were diluted depending on the urine
volume, normally 1:20, and 10 ml was used for analysis. To compare
24 h Ccr and FITC-inulin clearance, one 14-day-release 50 mg-FITC-
inulin pellet (Innovative Research of America, Sarasota, FL, USA)
was implanted subcutaneously to 3 months old C57BL/6J males. Six
days later animals were housed in metabolic cages to obtain 24 h
urine and plasma as described above, and simultaneous Ccr and
inulin clearance in the same animals were calculated as described
previously.2 In this experiment, the urine collection tube was
covered with aluminum foil to avoid exposure to the light. Ten
microliter of plasma, 1:100 diluted urine, or of cage wash was mixed
with 10 ml of 500 mM N-2-hydroxyethylpiperazine-N0-2-ethanesul-
phonic acid pH 7.4, and 30 ml phosphate-buffered saline, and FITC
fluorescence was determined with 485 nm excitation and 538 nm
emission. The linear range of the standard curve of FITC intensity
against FITC-inulin concentration is much narrower than that of
creatinine with LC-MS/MS, because the slope of the standard curve
becomes less steep when FITC concentrations are high. Therefore, it
is important to dilute urine before measurement to avoid under-
estimating the values.
Preparation of samples
For accurate quantitation, 9.6 ng (10 ml of 0.96 ng/ml) [2H3]-
creatinine and either 10 ml of urine that had been diluted with
water (1:100), 10 ml of the cage wash, or 10 ml plasma were added to
200 ml of absolute ethanol and vortexed, followed by centrifugation
at 12,000 r.p.m. in a microfuge for 15 min at 41C. The protein-free
supernatant was transferred to a new tube taking care not to remove
any particular matter, and solvent was removed under vacuum.
Plasma samples were then dissolved in 200 ml of water, extracted
twice with one volume chloroform, and 5 ml were analyzed by
LC-MS/MS. Note that the internal standard was added before
the protein precipitation to correct inconsistent recovery during
the ethanol precipitation, which ranged from 60 to 90%
(mean 80.1%) calculated from the amounts of internal standard
recovered. Deproteinized and evaporated urine samples or cage
washes were dissolved in 200 ml water and 5 ml were analyzed
directly by LC-MS/MS without chloroform extraction. To quantify
creatinine in the food, 5 g of food was mixed in 20 ml of water,
centrifuged, and 10 ml of the supernatant was deproteinized
and delipidated as described above before the analysis by LC-MS/
MS. The diets tested were regular chow Lab Diet 5001 and
vegetarian diets: 2016, TD.94045, and TD.96329 (Harlan Teklad,
Madison, WI, USA).
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Quantitative LC-MS/MS analyses of creatinine
The quantitative analysis of the creatinine by LC-MS/MS was
performed with a Surveyor LC coupled to a TSQ-Quantum Classic
triple quad mass analyzer (ThermoFinnigan, San Jose, CA, USA). A
2.0 150 mm YMC C18, 5 mm column was operated with a linear
gradient of 5% acetonitril 0.1% formic acid for 0.3 min, then to 95%
acetonitril 0.1% formic acid in 1 min at a flow rate of 200 ml/min.
During the first minute the effluent flow is diverted to waste to
prevent salts from entering the MS. The creatinine retention times
were determined with authentic standards. Creatinine and [2H3]-
creatinine were detected in single reaction monitoring mode,
monitoring the transitions of the m/z 114 to 44 and m/z 117 to
47, respectively. The MS and electro spay ionization parameters were
optimized by direct infusion of standard using the Xcalibur software
(ThermoFinnigan, San Jose, CA, USA). The conditions were as
follows: spray voltage 2200 V, heated capillary temperature 3501C.
Statistical analyses
Values are expressed as mean7s.e.m. unless mentioned. Data were
analyzed by linear fit, Student’s t-test or analysis of variance with
Tukey–Klamer post hoc test using JMP software version 6 (SAS
Institute Inc., Cary, NC, USA).
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